1. Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
   Shuai Zhen et al, 2018, Human Gene Therapy CrossRef
2. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway
   Xue Wu et al, 2017, BMC Cancer CrossRef
3. Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
   Vincent Jean-Pierre et al, 2021, Front. Microbiol. CrossRef
4. Epigenetics of Epstein Barr virus — A review
   Gadde Shareena et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
5. mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice
   Ge‐Xin Zhao et al, 2023, Advanced Science CrossRef